Previous close | 5.6500 |
Open | 4.2600 |
Bid | 4.0000 |
Ask | 6.4000 |
Strike | 230.00 |
Expiry date | 2024-08-16 |
Day's range | 4.2600 - 4.8000 |
Contract range | N/A |
Volume | |
Open interest | 128 |
Charles River (CRL) announces the development of non-clinical VCG with Sanofi to reduce the use of animals in research.
WILMINGTON, Mass., June 11, 2024--Charles River announces an integrated program, funded by a $1.3 million grant, to develop an in vitro alternative to inhalation toxicology studies
WILMINGTON, Mass., June 06, 2024--Charles River announces the opening of a new CRADL® facility on Chestnut Street in Somerville, Massachusetts, an emerging life sciences hub.